Lacrimal passage irrigation fluid for nursing of pediatric dacryocystitis

Abstract

The invention discloses lacrimal passage irrigation fluid for nursing of pediatric dacryocystitis. The lacrimal passage irrigation fluid is prepared from, by mass, 0.01-0.04% of (S)-ornidazole, 0.1-0.5% of antibacterial peptide, 0.01-0.03% of L-borneolum, 0.05-0.1% of aescin, 0.02-0.2% of obakunone, 0.02-0.05% of allantoin, 0.03-0.08% of naringenin, 0.005-0.1% of shikimic acid, 0.003-0.1% of cryptoxanthin, 0.01-0.1% of vitamin A, 0.03-0.06% of a surfactant and the balance water for injection. Compared with existing normal saline irrigation fluid, the lacrimal passage irrigation fluid for nursing of pediatric dacryocystitis has advantages that antibacterial and anti-inflammation effects are achieved, infection caused by anaerobic bacteria can be controlled especially, postoperative recovery of lacrimal duct probing is promoted, neural activity can be protected, and a function of maintaining eyesight health can be achieved to some extent.

Description

technical field

[0001] The invention relates to the technical field of nursing medicine for dacryocystitis, in particular to a lacrimal duct flushing solution for nursing of dacryocystitis in children. Background technique

[0002] Neonatal dacryocystitis is caused by secondary infection caused by the retention of tear fluid and bacteria in the lacrimal sac because the embryonic residual membrane at the lower end of the nasolacrimal duct does not degenerate and blocks the lower end of the nasolacrimal duct. Neonatal dacryocystitis is a relatively common eye disease, and the baby's eyes are often teary. There are a lot of thick secretions in the baby's eyes, and the age of onset can be early or late. Some have symptoms on the first day after birth, and some may appear about a week or a month later. Neonatal long-term dacryocystitis is a serious threat to the safety of the eyes. Progressive corneal ulcer or penetrating eye injury, intraocular surgery, etc. can cause panophth...